Investor Relations
Jan 07, 2019
OPKO Health Appoints Jon R. Cohen, M.D. Executive Chairman of BioReference Laboratories MORE >>
Dec 27, 2018
OPKO Health and OPKO's CEO and Chairman, Dr. Phillip Frost, Announce Proposed Resolution of SEC Action MORE >>
Nov 09, 2018
OPKO Health Reports Third Quarter 2018 Financial Results MORE >>
Nov 08, 2018
BioReference Laboratories Named as Preferred Laboratory with Horizon Healthcare Services MORE >>

SEC Filings

Form Description Filing date View
D View HTML
D View HTML
15-12G

15-12G    

View HTML
424B7

424B7    

View HTML
424B7

424B7    

View HTML
PRE 14C

A preliminary proxy statement containing all other information

View HTML
PRE 14C

A preliminary proxy statement containing all other information

View HTML
PRE 14C

A preliminary proxy statement containing all other information

View HTML
PRE 14C

A preliminary proxy statement containing all other information

View HTML
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

View HTML